List of Xencor patents

Patents where

Current Assignee

Name

Xencor

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7317091 Optimized Fc variants	Patent 7317091 was granted and assigned to Xencor on January, 2008 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	7317091	January 8, 2008
‌ US Patent 8367805 Fc variants with altered binding to FcRn	Patent 8367805 was granted and assigned to Xencor on February, 2013 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8367805	February 5, 2013
‌ US Patent 7657380 Methods of generating variant antibodies with increased host string content	Patent 7657380 was granted and assigned to Xencor on February, 2010 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	7657380	February 2, 2010
‌ US Patent 11591401 Anti-CD28 compositions	Patent 11591401 was granted and assigned to Xencor on February, 2023 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	11591401	February 28, 2023
‌ US Patent 11377477 PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof		Xencor	Xencor	United States Patent and Trademark Office	11377477	July 5, 2022
‌ US Patent 9605084 Heterodimeric proteins	Patent 9605084 was granted and assigned to Xencor on March, 2017 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	9605084	March 28, 2017
‌ US Patent 8362210 Antibody variants with enhanced complement activity	Patent 8362210 was granted and assigned to Xencor on January, 2013 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8362210	January 29, 2013
‌ US Patent 11492407 Bispecific checkpoint inhibitor antibodies	Patent 11492407 was granted and assigned to Xencor on November, 2022 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	11492407	November 8, 2022
‌ US Patent 10336818 Fc variants with altered binding to FcRn	Patent 10336818 was granted and assigned to Xencor on July, 2019 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	10336818	July 2, 2019
‌ US Patent 10968276 Optimized anti-CD3 variable regions	Patent 10968276 was granted and assigned to Xencor on April, 2021 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	10968276	April 6, 2021
‌ US Patent 10550185 Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments	Patent 10550185 was granted and assigned to Xencor on February, 2020 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	10550185	February 4, 2020
‌ US Patent 9051373 Optimized Fc variants	Patent 9051373 was granted and assigned to Xencor on June, 2015 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	9051373	June 9, 2015
‌ US Patent 9701759 Heterodimeric proteins	Patent 9701759 was granted and assigned to Xencor on July, 2017 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	9701759	July 11, 2017
‌ US Patent 10131710 Optimized antibody variable regions	Patent 10131710 was granted and assigned to Xencor on November, 2018 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	10131710	November 20, 2018
‌ US Patent 11053316 Optimized antibody variable regions	Patent 11053316 was granted and assigned to Xencor on July, 2021 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	11053316	July 6, 2021
‌ US Patent 11512122 IL-7-FC-fusion proteins	Patent 11512122 was granted and assigned to Xencor on November, 2022 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	11512122	November 29, 2022
‌ US Patent 8063187 Methods and compositions for inhibiting CD32B expressing cells	Patent 8063187 was granted and assigned to Xencor on November, 2011 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8063187	November 22, 2011
‌ US Patent 11299554 Heterodimeric proteins		Xencor	Xencor	United States Patent and Trademark Office	11299554	April 12, 2022
‌ US Patent 8084582 Optimized anti-CD20 monoclonal antibodies having Fc variants	Patent 8084582 was granted and assigned to Xencor on December, 2011 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8084582	December 27, 2011
‌ US Patent 7276585 Immunoglobulin variants outside the Fc region	Patent 7276585 was granted and assigned to Xencor on October, 2007 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	7276585	October 2, 2007
‌ US Patent 8637641 Antibodies with modified isoelectric points	Patent 8637641 was granted and assigned to Xencor on January, 2014 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8637641	January 28, 2014
‌ US Patent 8101720 Immunoglobulin insertions, deletions and substitutions	Patent 8101720 was granted and assigned to Xencor on January, 2012 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8101720	January 24, 2012
‌ US Patent 11358999 IL-12 heterodimeric Fc-fusion proteins	Patent 11358999 was granted and assigned to Xencor on June, 2022 by the United States Patent and Trademark Office.	Xencor	Xencor	United States Patent and Trademark Office	11358999	June 14, 2022
‌ US Patent 8394925 Fc variants with altered binding to FcRn	Patent 8394925 was granted and assigned to Xencor on March, 2013 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8394925	March 12, 2013
‌ US Patent 8088376 Fc variants with altered binding to FcRn	Patent 8088376 was granted and assigned to Xencor on January, 2012 by the United States Patent and Trademark Office.		Xencor	United States Patent and Trademark Office	8088376	January 3, 2012

...

Results per page:

181 results

0 selected

181 results

0 selected